You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

BACTRIM DS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Bactrim Ds patents expire, and what generic alternatives are available?

Bactrim Ds is a drug marketed by Sun Pharm Industries and is included in one NDA.

The generic ingredient in BACTRIM DS is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bactrim Ds

A generic version of BACTRIM DS was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BACTRIM DS?
  • What are the global sales for BACTRIM DS?
  • What is Average Wholesale Price for BACTRIM DS?
Summary for BACTRIM DS
Drug patent expirations by year for BACTRIM DS
Drug Prices for BACTRIM DS

See drug prices for BACTRIM DS

Recent Clinical Trials for BACTRIM DS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityEarly Phase 1
Melbourne HealthPhase 3
University of MalayaPhase 3

See all BACTRIM DS clinical trials

US Patents and Regulatory Information for BACTRIM DS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries BACTRIM DS sulfamethoxazole; trimethoprim TABLET;ORAL 017377-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for BACTRIM DS

See the table below for patents covering BACTRIM DS around the world.

Country Patent Number Title Estimated Expiration
Canada 1003331 COMPOSITION CONTAINING 5-METHYL-3- SULFANILAMIDOISOXAZOLE AND A BENZYL PYRIMIDINE ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.